StockData
NovaBridge Biosciences logo

NovaBridge Biosciences (NBP) stock

NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 0/30
$0.82+0.03 (+3.89%)

Close on Nov 17, 2026Market cap $94.88MP/E –Yield –

NovaBridge Biosciences enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

NovaBridge Biosciences's enterprise value was $99.34M on Nov 11, 2026, against $312.96M a year earlier. Over the last 5 years it ranged from -$360.64M to $2.65B, with a median of -$59.93M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$99.34M-69.4%
2025Dec 31, 2025$324.37M–
2024Dec 31, 2024-$240.30M–
2023Dec 29, 2023-$325.49M–
2022Dec 30, 2022-$221.30M-108.4%
2021Dec 31, 2021$2.65B-1.6%
2020Dec 31, 2020$2.69B–

More NovaBridge Biosciences figures

See a number that looks wrong?